Forkhead Biotherapeutics, Inc.
PrivateCompany Overview
Forkhead Biotherapeutics, Inc. is a biotechnology company that develops oral therapies for insulin-dependent diabetes by harnessing cell conversion and regeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
small molecule therapeuticsdrug discoverytranscription factor inhibitorsoncologyFOXO1 inhibitorspreclinical biotechchemical biologyundruggable targetsbiotech startupdrug pipelinesmall molecule drug discoverytherapeutic developmentbiopharma
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Forkhead Biotherapeutics, Inc. Comparables
Compare Forkhead Biotherapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flare Therapeutics | 81% | |
| Altay Therapeutics | 81% | |
| Recludix Pharma | 79% | |
Forkhead Biotherapeutics, Inc. Funding Rounds
Historical fundraising activity
Forkhead Biotherapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Forkhead Biotherapeutics, Inc.'s valuation, stock price, and market status.
See something wrong or outdated?